Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Dolichyl-diphosphooligosaccharide--protein glycosyltransferase subunit STT3A is the primary catalytic subunit of the oligosaccharyltransferase (OST) complex, which resides in the endoplasmic reticulum (ER) membrane (UniProt P46977). It is specifically responsible for co-translational N-glycosylation, a process where a pre-assembled oligosaccharide is transferred to the asparagine residue of a nascent polypeptide as it is being synthesized (PubMed: 25417110). This modification is essential for the correct folding, stability, and biological activity of a vast majority of secretory and membrane proteins. Mutations in the STT3A gene lead to congenital disorders of glycosylation (CDG-Iv), which manifest as severe developmental delays and neurological impairments (PubMed: 24532530). In therapeutic research, STT3A is targeted by small molecules like NGI-1 to disrupt the glycosylation of oncogenic receptors or viral glycoproteins, thereby inhibiting cancer progression or viral replication (PubMed: 27524445). However, because N-glycosylation is a fundamental cellular process, pharmacological targeting of STT3A carries a high risk of off-target toxicity and ER stress-induced cell death.
Inhibition of the catalytic subunit of the oligosaccharyltransferase complex to prevent the transfer of glycan chains to nascent polypeptides.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Dolichyl-diphosphooligosaccharide--protein glycosyltransferase subunit STT3A (STT3A).